The following license files are associated with this item:
- QMRO Home
- William Harvey Research Institute
- Centre for Endocrinology
- Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation-Positive Child
Browse
Administrators only